HCW Biologics Inc

HCWB

Latest QuantConomy context for HCWB: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class

stock

Primary venue

NASDAQ

Recent signals

SEC filings

Asset profile

QuantConomy has a structured record for HCWB. More descriptive asset metadata will appear here when the platform record includes it.

Latest signal rows

Recent signals for HCWB

Scored rows are pulled from the same signal API used by the digests.

Signal	Direction	Score	Observed	Reason
corporate event other event	neutral	70	Jul 1, 12:35 PM	HCWB filed 8-K: Other Events - 1 material event - [strong neutral signal]
corporate event delisting	very bearish	75	Jun 30, 12:35 PM	HCWB filed 8-K: Delisting Notice - 1 material event - [strong very bearish signal]
fundamental eps change	very bullish	76	May 14, 12:00 AM	HCWB (Q1 2026, diluted eps): EPS grew 93.6% ($-30.96 → $-1.97). [sequential period basis, very bullish signal]

FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.

Market	Exchange	Source	Asset record
HCWB	NASDAQ	alphavantage	HCW Biologics Inc
HCWB	NASDAQ	alpaca	HCW Biologics Inc. Common Stock
HCWB	NASDAQ	fmp	HCW Biologics Inc.

Buys, last 90d

Sells, last 90d

Rows

Date	Insider	Role	Type	Shares	Price	Value	Filing
May 22, 2026	GARRETT SCOTT T	Insider	purchase	177,936	$1.41	$250,000	4 on EDGAR
May 22, 2026	Byam Rebecca	Chief Financial Officer	purchase	14,235	$1.41	$20,000	4 on EDGAR
May 22, 2026	Wong Hing C	Chief Executive Officer	purchase	113,879	$1.41	$160,000	4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.